Effect of APOE alleles on the glial transcriptome in normal aging and Alzheimer’s disease

被引:0
|
作者
Alberto Serrano-Pozo
Zhaozhi Li
Ayush Noori
Huong N. Nguyen
Aziz Mezlini
Liang Li
Eloise Hudry
Rosemary J. Jackson
Bradley T. Hyman
Sudeshna Das
机构
[1] Massachusetts General Hospital,Department of Neurology
[2] Massachusetts Alzheimer’s Disease Research Center,undefined
[3] Harvard Medical School,undefined
来源
Nature Aging | 2021年 / 1卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The roles of APOEε4 and APOEε2—the strongest genetic risk and protective factors for Alzheimer’s disease—in glial responses remain elusive. We tested the hypothesis that APOE alleles differentially impact glial responses by investigating their effects on the glial transcriptome from elderly control brains with no neuritic amyloid plaques. We identified a cluster of microglial genes that are upregulated in APOEε4 and downregulated in APOEε2 carriers relative to APOEε3 homozygotes. This microglia-APOE cluster is enriched in phagocytosis—including TREM2 and TYROBP—and proinflammatory genes, and is also detectable in brains with frequent neuritic plaques. Next, we tested these findings in APOE knock-in mice exposed to acute (lipopolysaccharide challenge) and chronic (cerebral β-amyloidosis) insults and found that these mice partially recapitulate human APOE-linked expression patterns. Thus, the APOEε4 allele might prime microglia towards a phagocytic and proinflammatory state through an APOE–TREM2–TYROBP axis in normal aging as well as in Alzheimer’s disease.
引用
收藏
页码:919 / 931
页数:12
相关论文
共 50 条
  • [31] Systemic inflammation, infection, apoE alleles, and Alzheimer disease: A position paper
    Finch, Caleb E.
    Morgan, Todd E.
    CURRENT ALZHEIMER RESEARCH, 2007, 4 (02) : 185 - 189
  • [32] Alzheimer’s disease beyond APOE
    Michael A van Es
    Leonard H van den Berg
    Nature Genetics, 2009, 41 : 1047 - 1048
  • [33] Apoe and memory in Alzheimer's disease
    Soininen, HS
    Riekkinen, PJ
    PROGRESS IN ALZHEIMER'S AND PARKINSON'S DISEASES, 1998, 49 : 13 - 16
  • [34] Neprylisin decreases uniformly in Alzheimer's disease and in normal aging
    Russo, R
    Borghi, R
    Markesbery, W
    Tabaton, M
    Piccini, A
    FEBS LETTERS, 2005, 579 (27) : 6027 - 6030
  • [35] Effects of Normal Aging and Alzheimer's Disease on Emotional Memory
    Kensinger, Elizabeth A.
    Brierley, Barbara
    Medford, Nick
    Growdon, John H.
    Corkin, Suzanne
    EMOTION, 2002, 2 (02) : 118 - 134
  • [36] Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease
    Nativio, Raffaella
    Donahue, Greg
    Berson, Amit
    Lan, Yemin
    Amlie-Wolf, Alexandre
    Tuzer, Ferit
    Toledo, Jon B.
    Gosai, Sager J.
    Gregory, Brian D.
    Torres, Claudio
    Trojanowski, John Q.
    Wang, Li-San
    Johnson, F. Brad
    Bonini, Nancy M.
    Berger, Shelley L.
    NATURE NEUROSCIENCE, 2018, 21 (04) : 497 - +
  • [37] Cerebrospinal Fluid Epinephrine in Alzheimer's Disease and Normal Aging
    Elaine R Peskind
    Rachael Elrod
    Dorcas J Dobie
    Marcella Pascualy
    Eric Petrie
    Carl Jensen
    Kayla Brodkin
    Sharon Murray
    Richard C Veith
    Murray A Raskind
    Neuropsychopharmacology, 1998, 19 : 465 - 471
  • [38] Alzheimer's disease and normal aging: Neurophysiological and immunological aspects
    Ivnev, BB
    NEUROPHYSIOLOGY, 1999, 31 (01) : 23 - 25
  • [39] Cortical variability and asymmetry in normal aging and Alzheimer's disease
    Thompson, PM
    Moussai, J
    Zohoori, S
    Goldkorn, A
    Khan, AA
    Mega, MS
    Small, GW
    Cummings, JL
    Toga, AW
    CEREBRAL CORTEX, 1998, 8 (06) : 492 - 509
  • [40] The cognitive transition from normal aging to Alzheimer's disease
    Bäckman, L
    BRAIN AND COGNITION, 1999, 39 (01) : 5 - 6